Skip to main content
Key Specialties
Cardiology Diabetology Endocrinology Gastroenterology Geriatrics and Gerontology Gynecology and Obstetrics Hematology Infectious Disease Internal Medicine Nephrology Neurology Oncology Pediatrics Respiratory Medicine Rheumatology Surgery
Congress Coverage
2024 ACC Congress 2023 ESMO Congress 2023 EASD Congress 2023 ERS Congress 2023 ESC Congress 2023 EHA Congress 2023 ASCO Annual Meeting
Clinical Collections
Advances in Alzheimer’s

Keynote webinar | Spotlight on sleep in brain health

LIVE: Thursday 2nd May 2024, 18:00-19:30 (CEST)

Quality sleep is essential for health. But what happens to our brains when sleep patterns are disturbed? Join our experts to explore the interplay between sleep disruption and neurological diseases, and the questions that you need to be asking your patients to help you prevent the harmful effects of sleep deprivation.
ADVANCED SEARCH
Log in
Top
International Journal of Mental Health and Addiction
Published in: International Journal of Mental Health and Addiction 5/2018

01-10-2018 | Original Article

The Correlation between Methadone Dosages among Pairs of Heroin Users in Romantic Relationships and among Pairs of Heroin Users Who Are Siblings

Authors: Wei-Lieh Huang, Yi-Ling Chien, Chi-Sin Wu

Published in: International Journal of Mental Health and Addiction | Issue 5/2018

Login to get access

Abstract

This study explores whether an individual’s methadone dose is influenced by the level of another individual’s dose as a function of their relationship. Thirty-four subjects were recruited in this study; 16 subjects were in a partner relationship and 18 subjects were siblings. Multiple regression analysis revealed that the dose of one member of the dyad was a predictor of the dose of the other member of the dyad. Mean difference in dose was negatively associated with the correlation coefficient in sibling dyads but not partner dyads. Analysis of the dose curves showed that all partner dyads demonstrated a “collinearity pattern” or “coexistence pattern,” but a “distinct trend pattern” was only noted in sibling dyads. Our results suggest that there is a relationship between the methadone doses of members of a dyad and that this phenomenon is more remarkable in partnership dyads than sibling dyads.
Literature
Baumeister, M., Vogel, M., Dursteler-MacFarland, K. M., Gerhard, U., Strasser, J., Walter, M., Wiesbeck, G. A., & Petitjean, S. A. (2014). Association between methadone dose and concomitant cocaine use in methadone maintenance treatment: a register-based study. Substance Abuse Treatment, Prevention, and Policy, 9, 46.CrossRef
Belding, M. A., McLellan, A. T., Zanis, D. A., & Incmikoski, R. (1998). Characterizing “nonresponsive” methadone patients. Journal of Substance Abuse Treatment, 15(6), 485–492.CrossRef
Caplehorn, J. R. M., Bell, J., Kleinbaum, D. G., & Gebski, V. J. (1993). Methadone dose and heroin use during maintenance treatment. Addiction, 88(1), 119–124.CrossRef
Chen, I. M., Huang, C. L., Yeh, B. J., & Chien, Y. L. (2015). Health service utilization of heroin abusers: a retrospective cohort study. Addiction Behavior, 45, 281–286.CrossRef
Clarke, S., Delamere, S., McCullough, L., Hopkins, S., Bergin, C., & Mulcahy, F. (2003). Assessing limiting factors to the acceptance of antiretroviral therapy in a large cohort of injecting drug users. HIV Medicine, 4(1), 33–37.CrossRef
Curry, A. D., & Latkin, C. A. (2003). Gender differences in street economy and social network correlates of arrest among heroin injectors in Baltimore, Maryland. Journal of Urban Health, 80(3), 482–493.CrossRef
D'Aunno, T., Pollack, H. A., Frimpong, J. A., & Wuchiett, D. (2014). Evidence-based treatment for opioid disorders: a 23-year national study of methadone dose levels. Journal of Subtance Abuse Treatment, 47(4), 245–250.CrossRef
de Dios, M. A., Stanton, C. A., Caviness, C. M., Niaura, R., & Stein, M. (2013). The social support and social network characteristics of smokers in methadone maintenance treatment. American Journal of Drug and Alcohol Abuse, 39(1), 50–56.CrossRef
Degenhardt, L., Charlson, F., Mathers, B., Hall, W. D., Flaxman, A. D., Johns, N., & Vos, T. (2014). The global epidemiology and burden of opioid dependence: results from the global burden of disease 2010 study. Addiction, 109(8), 1320–1333.CrossRef
Dinis-Oliveira, R. J. (2016). Metabolomics of methadone: clinical and forensic toxicological implications and variability of dose response. Drug Metabolism Reviews, 48(4), 568–576.CrossRef
Fry, C., & Dwyer, R. (2001). For love or money? An exploratory study of why injecting drug users participate in research. Addiction, 96(9), 1319–1325.CrossRef
Gossop, M., Griffiths, P., Powis, B., & Strang, J. (1993). Severity of heroin dependence and HIV risk. II. Sharing injecting equipment. AIDS Care, 5(2), 159–168.CrossRef
Hartel, D. M., Schoenbaum, E. E., Selwyn, P. A., Kline, J., Davenny, K., Klein, R. S., & Friedland, G. H. (1995). Heroin use during methadone-maintenance treatment—the importance of methadone dose and cocaine use. American Journal of Public Health, 85(1), 83–88.CrossRef
Irwin, H. J. (1995). Codependence, narcissism, and childhood trauma. Journal of Clinical Psychology, 51(5), 658–665.CrossRef
Joseph, H., Stancliff, S., & Langrod, J. (2000). Methadone maintenance treatment (MMT): a review of historical and clinical issues. Mt Sinai Journal of Medicine, 67(5–6), 347–364.
Kakko, J., Gronbladh, L., Svanborg, K. D., von Wachenfeldt, J., Ruck, C., Rawlings, B., Nilsson, L. H., & Heilig, M. (2007). A stepped care strategy using buprenorphine and methadone versus conventional methadone maintenance in heroin dependence: a randomized controlled trial. American Journal of Psychiatry, 164(5), 797–803.CrossRef
Kelly, P. J., Ramaswamy, M., Li, X., Litwin, A. H., Berg, K. M., & Arnsten, J. H. (2012). Social networks of substance users with HIV infection: application of the Norbeck Social Support Scale. Western Journal of Nursing Research, 34(5), 621–634.CrossRef
Kim, N. J., Jin, H., McFarland, W., & Raymond, H. F. (2015). Trends in sources and sharing of needles among people who inject drugs, San Francisco, 2005–2012. The International Journal on Drug Policy, 26(12), 1238–1243.CrossRef
Ko, N. Y., Hsu, S. T., Chen, C. H., Lee, H. C., & Ko, W. C. (2011). Heroin dependence and bloodborne virus transmission behaviors for HIV infection among newly incarcerated injection drug users in Taiwan. Substance Use and Misuse, 46(5), 591–598.CrossRef
Kreek, M. J., Borg, L., Ducat, E., & Ray, B. (2010). Pharmacotherapy in the treatment of addiction: methadone. Journal of Addict Disorders, 29(2), 200–216.CrossRef
Latowsky, M. (1996). Improving detoxification outcomes from methadone maintenance treatment: the interrelationship of affective states and protracted withdrawal. Journal of Psychoactive Drugs, 28(3), 251–257.CrossRef
Lin, H. C., Chen, K. Y., Wang, P. W., Yen, C. F., Wu, H. C., Yen, C. N., & Chang, H. C. (2013). Predictors for dropping-out from methadone maintenance therapy programs among heroin users in southern Taiwan. Substance Use and Misuse, 48(1–2), 181–191.CrossRef
Lions, C., Carrieri, M. P., Michel, L., Mora, M., Marcellin, F., Morel, A., et al. (2014). Predictors of non-prescribed opioid use after one year of methadone treatment: an attributable-risk approach (ANRS-Methaville trial). Drug and Alcohol Dependence, 135, 1–8.CrossRef
Merikangas, A. K., Segurado, R., Cormican, P., Heron, E. A., Anney, R. J., Moore, S., et al. (2014). The phenotypic manifestations of rare CNVs in schizophrenia. Schizophrenia Research, 158(1–3), 255–260.CrossRef
Mouly, S., Bloch, V., Peoc'h, K., Houze, P., Labat, L., Ksouda, K., et al. (2015). Methadone dose in heroin-dependent patients: role of clinical factors, comedications, genetic polymorphisms and enzyme activity. British Journal of Clinical Pharmacology, 79(6), 967–977.CrossRef
Neaigus, A., Friedman, S. R., Curtis, R., Jarlais, D. C. D., Furst, R. T., Jose, B., et al. (1994). The relevance of drug injectors social and risk networks for understanding and preventing HIV-infection. Social Science & Medicine, 38(1), 67–78.CrossRef
Noor, S. W., Ross, M. W., Lai, D., & Risser, J. M. (2013). Clustered drug and sexual HIV risk among a sample of middle-aged injection drug users, Houston, Texas. AIDS Care, 25(7), 895–903.CrossRef
Nutt, D., King, L. A., Saulsbury, W., & Blakemore, C. (2007). Development of a rational scale to assess the harm of drugs of potential misuse. Lancet, 369(9566), 1047–1053.CrossRef
Panaghi, L., Ahmadabadi, Z., Khosravi, N., Sadeghi, M. S., & Madanipour, A. (2016). Living with addicted men and codependency: the moderating effect of personality traits. Addiction and Health, 8(2), 98–106.PubMed
Peles, E., Schreiber, S., Hetzroni, T., Adelson, M., & Defrin, R. (2011). The differential effect of methadone dose and of chronic pain on pain perception of former heroin addicts receiving methadone maintenance treatment. The Journal of Pain, 12(1), 41–50.CrossRef
Pivnick, A., Jacobson, A., Eric, K., Doll, L., & Drucker, E. (1994). AIDS, HIV-infection, and illicit drug-use within inner-city families and social networks. American Journal of Public Health, 84(2), 271–274.CrossRef
Preston, K. L., Umbricht, A., & Epstein, D. H. (2000). Methadone dose increase and abstinence reinforcement for treatment of continued heroin use during methadone maintenance. Archives of General Psychiatry, 57(4), 395–404.CrossRef
Roux, P., Lions, C., Michel, L., Mora, M., Daulouede, J. P., Marcellin, F., … Anrs Methaville Study Group. (2014). Factors associated with HCV risk practices in methadone-maintained patients: the importance of considering the couple in prevention interventions. Substance Abuse Treatment, Prevention, and Policy, 9, 37.CrossRef
Simmons, J., & Singer, M. (2006). I love you… and heroin: care and collusion among drug-using couples. Substance Abuse Treatment, Prevention, and Policy, 1, 7.CrossRef
Stein, M. D., Anderson, B. J., Thurmond, P., & Bailey, G. L. (2015). Comparing the life concerns of prescription opioid and heroin users. Journal of Substance Abuse Treatment, 48(1), 43–48.CrossRef
Unger, J. B., Kipke, M. D., De Rosa, C. J., Hyde, J., Ritt-Olson, A., & Montgomery, S. (2006). Needle-sharing among young IV drug users and their social network members: the influence of the injection partner’s characteristics on HIV risk behavior. Addictive Behaviors, 31(9), 1607–1618.CrossRef
Volavka, J., Verebey, K., Resnick, R., & Mule, S. (1978). Methadone dose, plasma level, and cross-tolerance to heroin in man. Journal of Nervous and Mental Disorders, 166(2), 104–109.CrossRef
Metadata
Title
The Correlation between Methadone Dosages among Pairs of Heroin Users in Romantic Relationships and among Pairs of Heroin Users Who Are Siblings
Authors
Wei-Lieh Huang
Yi-Ling Chien
Chi-Sin Wu
Publication date
01-10-2018
Publisher
Springer US
Published in
International Journal of Mental Health and Addiction / Issue 5/2018
Print ISSN: 1557-1874
Electronic ISSN: 1557-1882
DOI
https://doi.org/10.1007/s11469-017-9858-4

Other articles of this Issue 5/2018

International Journal of Mental Health and Addiction 5/2018 Go to the issue

Original Article

Alcohol Text Messages: A Developmental Study

Original Article

The Impact of Animal-Assisted Intervention on Staff in a Seniors Residential Care Facility

Original Article

Do Addictive Behaviors Matter for College Students’ Depression and Suicidal Ideation?

Original Article

Alcohol Use in Context: a Psychosocial Investigation of Drinking Behaviors in a Diverse Community Sample in the United States

Original Article

Computer Gaming Disorder and ADHD in Young Children—a Population-Based Study

Original Article

Determinants of Anxiety and Depression Among University Students of Lahore